DT&CRO CO., Ltd. Logo

DT&CRO CO., Ltd.

A full-service CRO for pharma & biotech, from non-clinical studies to FDA approval support.

383930 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
경기도 용인시 처인구 백령로20번길 28 나동 2, 3, 4층(유방동), 용인시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

DT&CRO CO., Ltd. is a full-service Contract Research Organization (CRO) that provides comprehensive development support for the pharmaceutical, biotechnology, medical device, and chemical industries. The company offers a complete suite of services covering the entire product lifecycle, from non-clinical GLP toxicity studies, pharmacokinetic (PK) tests, and efficacy evaluations to clinical trials. A key specialization is its "Full Package Service" for U.S. FDA approval, offering end-to-end consulting and application support for Investigational New Drug (IND) and New Drug Application (NDA) submissions. DT&CRO is also noted for being the first Korean organization to develop an in-house CDISC SEND program for standardized data submission and offers MoPS, a proprietary IT platform for real-time project management and client communication.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for DT&CRO CO., Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all DT&CRO CO., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for DT&CRO CO., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Nykode Therapeutics ASA Logo
Developing novel immunotherapies and vaccines for cancer with its antigen-targeting platform.
Norway NYKD
Oculis Holding AG Logo
Clinical-stage biopharma developing non-invasive eye drops for sight-threatening diseases.
Switzerland OCS
OLIPASS CORPORATION Logo
Biotech firm developing RNA therapeutics for diseases with its proprietary OPNA platform.
South Korea 244460
Oncocross Co.,Ltd. Logo
AI-powered biotech accelerating drug development for cancer and rare diseases.
South Korea 382150
Onconic Therapeutics Inc. Logo
Develops novel drugs for cancer and GI diseases, including a next-gen acid blocker.
South Korea 476060
OncoTherapy Science, Inc. Logo
Develops targeted cancer therapies and provides TCR repertoire analysis services.
Japan 4564
Onxeo Logo
Developing precision-guided therapeutics using small antibodies for complex diseases.
France ALONX
Openedges Technology, Inc. Logo
Semiconductor IP provider of memory subsystem & AI platform IP for AI, HPC, and IoT SoCs.
South Korea 394280
Openjobmetis Logo
Employment agency providing staffing, recruitment, and HR services to companies and job seekers.
Italy OJM
Open Up Group Inc. Logo
Provides staffing and outsourcing of engineers for global manufacturing, IT, and construction sectors.
Japan 2154

Talk to a Data Expert

Have a question? We'll get back to you promptly.